查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1587486

北美非处方保健品市场规模、份额和趋势分析：2025-2030 年按应用、形式、产品、人口、分销渠道和细分市场进行的预测

North America OTC Health Products Market Size, Share & Trends Analysis By Application (Digestive Health, Women's Health), By Form (Liquid, Gummies), By Product, By Demography, By Distribution Channel, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

北美非处方保健品市场成长与趋势：

Grand View Research, Inc.最新报告显示，2030年北美OTC保健品市场规模预计将达到1066.1亿美元，2025年至2030年复合年增长率为6.15%。

消费者对营养食品的认识和消费意愿的提高、与文明病（包括肥胖和糖尿病）患病率的上升、可支配收入的增加以及非处方药产品分销渠道的增加将推动增长。消费者越来越意识到营养食品的好处，可以帮助他们维持健康的生活方式，对市场成长产生正面影响。根据美国国立美国每年在减重营养食品（通常是锭剂）上美国约 21 亿美元。

电子商务的出现增加了获得营养食品的机会。除线上管道外，主要零售商包括 General Nutrition Centers, Inc.、沃尔玛和 Vitamin Shoppe。因此，这些产品的容易获得为该领域的主要参与者提供了成长机会。此外，消费者对 CBD 的偏好的改变预计将推动 CBD 产品的成长潜力，因为 CBD 具有舒缓作用，几乎没有精神作用。根据盖洛普 2019 年的报告，大约 14% 的美国使用过某种形式的 CBD 注入产品。大约 58% 的成年人使用它来治疗疼痛相关症状，大约 42% 的成年人使用它来治疗心理健康相关症状。

COVID-19 大流行急剧增加了消费者对增强免疫力补充品的偏好。由于政府为遏制疫情而采取的限制措施，运动营养品、男女保健食品等行业受到了负面影响。自 2020 年第三季以来，COVID-19 的影响有所减弱，有助于市场復苏。

由于大量公司的存在，市场变得分散，导致竞争公司之间的敌对关係加剧。每家公司都建立了多个联盟和併购，扩大了其产品组合併扩大了在全国各地的足迹。此外，公司还注重产品差异化和捆绑策略，以获取更大的市场占有率。例如，CV Sciences 于 2022 年 3 月推出了 PlusCBD Relief 软胶囊。该公司声称它可以提供比原始配方好 7 倍的大麻二酚酸 (CBDA) 和大麻二酚 (CBD)。本品对治疗发炎反应具有临床意义。

北美非处方保健品市场报告重点：

  • 2024年，营养食品和减重产品细分市场占比为33.71%。这是由于消费者对健康饮食益处的认识不断增强、自我健康意识增强以及肥胖盛行率上升。
  • 由于人们对健身的认识不断提高以及运动营养品的高商业性可用性，运动配方细分市场在 2024 年将占据最大份额，达到 22.24%。
  • 由于成人市场有各种各样的非处方药产品，预计成人市场在预测期内将出现最快的成长。
  • 2024年，大卖场、超级市场和便利商店将主导市场。
  • 2024年，胶囊和锭剂占据市场主导地位。这是由于市场上胶囊和锭剂形式的产品广泛存在，不断增加的技术创新以增强胶囊和锭剂的递送形式，以及更长的保质期。
  • 美国在收益方面占据市场主导地位，主要是由于主要企业的存在、慢性病和肥胖症盛行率的增加以及人口迅速增长的老龄化。

目录

第一章调查方法和范围

第 2 章执行摘要

第 3 章北美非处方保健品市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 北美OTC保健品市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章 北美OTC保健品市场：产品预估及趋势分析

  • 细分仪表板
  • 北美OTC保健品市场：产品变异分析
  • 北美非处方保健品市场：按产品分類的展望
  • 2018-2030年市场规模、预测及趋势分析
  • 预防咳嗽、感冒和流感的产品
    • 液体
    • 胶囊/锭剂
    • 软糖
    • 其他的
  • 营养食品和减重产品
    • 液体
    • 胶囊/锭剂
    • 软糖
    • 其他的
  • 运动营养产品
    • 液体
    • 胶囊/锭剂
    • 软糖
    • 其他的
  • 益生菌
    • 液体
    • 胶囊/锭剂
    • 软糖
    • 其他的
  • CBD食品补充剂
    • 液体
    • 胶囊/锭剂
    • 软糖
    • 其他的

第五章 北美OTC保健品市场：业态预估及趋势分析

  • 细分仪表板
  • 北美OTC保健品市场：业态变化分析
  • 北美非处方保健品市场按业态展望
  • 2018-2030年市场规模、预测及趋势分析
  • 液体
  • 胶囊/锭剂
  • 软糖
  • 其他的

第六章 北美OTC保健品市场：应用预估及趋势分析

  • 细分仪表板
  • 北美OTC保健品市场：应用变化分析
  • 北美非处方保健品市场，依应用前景
  • 2018-2030年市场规模、预测及趋势分析
  • 消化器官系统健康
  • 女性和男性的健康
  • 体重管理
  • 关节健康
  • 免疫防御
  • 运动配方
  • 其他的

第七章 北美OTC保健品市场：人口统计估计及趋势分析

  • 细分仪表板
  • 北美非处方保健品市场：人口统计分析
  • 按人口统计的北美非处方药保健品市场展望
  • 2018-2030年市场规模、预测及趋势分析
  • 孩子
  • 成人

第八章北美OTC保健品市场：通路估算及趋势分析

  • 细分仪表板
  • 北美OTC保健品市场：通路变化分析
  • 北美非处方保健品市场：按分销管道分類的展望
  • 2018-2030年市场规模、预测及趋势分析
  • 零售药房
  • 在线的
  • 大型超级市场、超级市场、便利商店
  • 其他的

第九章北美非处方保健品市场：区域估计和趋势分析

  • 区域仪表板
  • 2018-2030年市场规模及预测趋势分析：
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥

第10章竞争格局

  • 市场参与企业分类
  • 主要市场参与企业的最新趋势和影响分析
  • 2024 年企业市场占有率分析
  • 主要企业简介
    • Herbalife Nutrition
    • CV Sciences, Inc.
    • Medical Marijuana Inc.
    • Nature's Sunshine Products Inc.
    • Johnson and Johnson Services, LLC
    • GlaxoSmithKline Inc.
    • Bayer AG
    • American Health
    • THE BOUNTIFUL COMPANY（Nestle Health Science SA）
Product Code: GVR-4-68039-951-7

North America OTC Health Products Market Growth & Trends:

The North America OTC health products market size is expected to reach USD 106.61 billion by 2030, expanding at a CAGR of 6.15% from 2025 to 2030, according to a new report by Grand View Research, Inc. Rising consumer awareness and increasing consumer willingness to spend on nutritional supplements, the increasing prevalence of lifestyle diseases including obesity & diabetes, rise in disposable income, and an increase in the number of distribution channels for OTC products are some of the key factors driving growth. Consumers are increasingly realizing the benefits of nutritional supplements, which help them sustain a healthy lifestyle, thereby positively impacting the market growth. According to the National Institute of Health, Americans spend around USD 2.1 billion annually on weight-loss dietary supplements, usually in the form of pills.

The emergence of e-commerce has led to increased accessibility to dietary and nutritional supplements. Apart from the online channels, companies such as General Nutrition Centers, Inc.; Walmart; and Vitamin Shoppe are some of the major retail outlets. Thus, the easy availability of these products will provide growth opportunities to key players in this space. Moreover, shifting consumer preference to CBD due to its healing properties and limited to no psychoactive effects is expected to drive the growth potential for CBD-infused products. According to Gallup, Inc. report of 2019, approximately 14% of individuals in the U.S. have used some or the other form of CBD-infused products. About 58% of adults use it for pain-related conditions and around 42% for mental health-related conditions.

The COVID-19 pandemic resulted in a surge in consumer preference for immunity-boosting supplements. Segments such as sports nutrition, and women's & men's health saw a negative impact due to lockdowns imposed by governments to curb the pandemic. The effect of COVID-19 declined post the third quarter of 2020, which helped the market regain traction.

The market is fragmented with the presence of a large number of companies, intensifying the overall competitive rivalry. Companies are undertaking multiple partnerships and mergers & acquisitions to increase their portfolio & expand their footprint across the country. In addition, companies are focusing on product differentiation and bundling strategies to capture a greater market share. For instance, in March 2022, CV Sciences, Inc. launched PlusCBD Relief Softgels. The company claims that it can deliver seven times better Cannabidiol Acid (CBDA) and Cannabidiol (CBD) than its raw formula. This product has clinical significance in the treatment of inflammatory responses.

North America OTC Health Products Market Report Highlights:

  • The dietary supplements and weight loss products segment accounted for 33.71% of the share in 2024. This is attributed to an increase in consumer awareness about the benefits of a healthy diet, growing self-health consciousness, and a rise in the prevalence of obesity
  • The sports formulation segment accounted for the largest share of 22.24% in 2024 due to rising awareness about fitness and high commercial availability of sports nutrition
  • Adults segment is projected to witness the fastest growth during the forecast period owing to the availability of a wide variety of OTC products for the adult demographic
  • Hypermarkets, supermarkets, and convenience stores dominated the market in 2024, owing to the better feasibility of buying from such places and an increase in the number of strategic initiatives like schemes such as loyalty programs
  • The capsules & tablets segment dominated the market in 2024. This can be attributed to the wide availability of products in capsule & tablet form in the market, the rise in innovation to enhance capsules & tablets delivery forms, and higher shelf-life
  • The U.S. dominated the market in terms of revenue, mainly due to the presence of key players, an increase in the prevalence of chronic diseases & obesity, and a rapidly growing geriatric population

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. Form
    • 1.2.4. Demography
    • 1.2.5. Distribution Channel
    • 1.2.6. Country Scope
    • 1.2.7. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Country outlook
  • 2.4. Competitive Insights

Chapter 3. North America OTC Health Products Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising Consumer Demand for Self-Care
      • 3.2.1.2. Expansion of Product Offerings
      • 3.2.1.3. Aging Population
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Regulatory Challenges
      • 3.2.2.2. Competition from Prescription Drugs
  • 3.3. North America OTC Health Products Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. North America OTC Health Products Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. North America OTC Health Products Market: Product Movement Analysis
  • 4.3. North America OTC Health Products Market by Product Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Cough, Cold, and Flu Products
    • 4.5.1. Liquid
      • 4.5.1.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. Capsules/Tablets
      • 4.5.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.3. Gummies
      • 4.5.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.4. Others
      • 4.5.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Dietary Supplements and Weight Loss Products
    • 4.6.1. Liquid
      • 4.6.1.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.2. Capsules/Tablets
      • 4.6.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.3. Gummies
      • 4.6.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.4. Others
      • 4.6.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Sports Nutrition Products
    • 4.7.1. Liquid
      • 4.7.1.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.7.2. Capsules/Tablets
      • 4.7.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.7.3. Gummies
      • 4.7.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.7.4. Others
      • 4.7.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. Probiotics
    • 4.8.1. Liquid
      • 4.8.1.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.8.2. Capsules/Tablets
      • 4.8.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.8.3. Gummies
      • 4.8.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.8.4. Others
      • 4.8.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.9. CBD Nutraceutical Products
    • 4.9.1. Liquid
      • 4.9.1.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.9.2. Capsules/Tablets
      • 4.9.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.9.3. Gummies
      • 4.9.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.9.4. Others
      • 4.9.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. North America OTC Health Products Market: Form Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. North America OTC Health Products Market: Form Movement Analysis
  • 5.3. North America OTC Health Products Market by Form Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Liquid
    • 5.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Capsules/Tablets
    • 5.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Gummies
    • 5.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Others
    • 5.8.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. North America OTC Health Products Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. North America OTC Health Products Market: Application Movement Analysis
  • 6.3. North America OTC Health Products Market by Application Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5. Digestive health
    • 6.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Women's & Men's Health
    • 6.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Weight Control
    • 6.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. Joint health
    • 6.8.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.9. Immune Defense
    • 6.9.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.10. Sports Formulation
    • 6.10.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.11. Others
    • 6.11.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. North America OTC Health Products Market: Demography Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. North America OTC Health Products Market: Demography Movement Analysis
  • 7.3. North America OTC Health Products Market by Demography Outlook (USD Million)
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 7.5. Children
    • 7.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Adults
    • 7.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. North America OTC Health Products Market: Distribution Channel Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. North America OTC Health Products Market: Distribution Channel Movement Analysis
  • 8.3. North America OTC Health Products Market by Distribution Channel Outlook (USD Million)
  • 8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 8.5. Retail pharmacies
    • 8.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Online
    • 8.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7. Hypermarkets, supermarkets, convenience stores
    • 8.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8. Others
    • 8.8.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. North America OTC Health Products Market: Regional Estimates & Trend Analysis

  • 9.1. Regional Dashboard
  • 9.2. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 9.3. North America
    • 9.3.1. U.S.
      • 9.3.1.1. Key country dynamics
      • 9.3.1.2. Regulatory framework/ reimbursement structure
      • 9.3.1.3. Competitive scenario
      • 9.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.3.2. Canada
      • 9.3.2.1. Key country dynamics
      • 9.3.2.2. Regulatory framework/ reimbursement structure
      • 9.3.2.3. Competitive scenario
      • 9.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.3.3. Mexico
      • 9.3.3.1. Key country dynamics
      • 9.3.3.2. Regulatory framework/ reimbursement structure
      • 9.3.3.3. Competitive scenario
      • 9.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Market Participant Categorization
  • 10.2. Recent Developments & Impact Analysis by Key Market Participants
  • 10.3. Company Market Share Analysis, 2024
  • 10.4. Key Company Profiles
    • 10.4.1. Herbalife Nutrition
      • 10.4.1.1. Company overview
      • 10.4.1.2. Financial performance
      • 10.4.1.3. Product benchmarking
      • 10.4.1.4. Strategic initiatives
    • 10.4.2. CV Sciences, Inc.
      • 10.4.2.1. Company overview
      • 10.4.2.2. Financial performance
      • 10.4.2.3. Product benchmarking
      • 10.4.2.4. Strategic initiatives
    • 10.4.3. Medical Marijuana Inc.
      • 10.4.3.1. Company overview
      • 10.4.3.2. Financial performance
      • 10.4.3.3. Product benchmarking
      • 10.4.3.4. Strategic initiatives
    • 10.4.4. Nature's Sunshine Products Inc.
      • 10.4.4.1. Company overview
      • 10.4.4.2. Financial performance
      • 10.4.4.3. Product benchmarking
      • 10.4.4.4. Strategic initiatives
    • 10.4.5. Johnson and Johnson Services, LLC
      • 10.4.5.1. Company overview
      • 10.4.5.2. Financial performance
      • 10.4.5.3. Product benchmarking
      • 10.4.5.4. Strategic initiatives
    • 10.4.6. GlaxoSmithKline Inc.
      • 10.4.6.1. Company overview
      • 10.4.6.2. Financial performance
      • 10.4.6.3. Product benchmarking
      • 10.4.6.4. Strategic initiatives
    • 10.4.7. Bayer AG
      • 10.4.7.1. Company overview
      • 10.4.7.2. Financial performance
      • 10.4.7.3. Product benchmarking
      • 10.4.7.4. Strategic initiatives
    • 10.4.8. American Health
      • 10.4.8.1. Company overview
      • 10.4.8.2. Financial performance
      • 10.4.8.3. Product benchmarking
      • 10.4.8.4. Strategic initiatives
    • 10.4.9. THE BOUNTIFUL COMPANY (Nestle Health Science S.A.)
      • 10.4.9.1. Company overview
      • 10.4.9.2. Financial performance
      • 10.4.9.3. Product benchmarking
      • 10.4.9.4. Strategic initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. North America OTC health products market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
  • Table 4. North America OTC health products market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
  • Table 5. North America OTC health products market estimates and forecasts, by form, 2018 - 2030 (USD Billion)
  • Table 6. North America OTC health products market estimates and forecasts, by demography, 2018 - 2030 (USD Billion)
  • Table 7. North America OTC health products market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 8. U.S. OTC health products market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
  • Table 9. U.S. OTC health products market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
  • Table 10. U.S. OTC health products market estimates and forecasts, by form, 2018 - 2030 (USD Billion)
  • Table 11. U.S. OTC health products market estimates and forecasts, by demography, 2018 - 2030 (USD Billion)
  • Table 12. U.S. OTC health products market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 13. Canada OTC health products market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
  • Table 14. Canada OTC health products market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
  • Table 15. Canada OTC health products market estimates and forecasts, by form, 2018 - 2030 (USD Billion)
  • Table 16. Canada OTC health products market estimates and forecasts, by demography, 2018 - 2030 (USD Billion)
  • Table 17. Canada OTC health products market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 18. Mexico OTC health products market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
  • Table 19. Mexico OTC health products market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
  • Table 20. Mexico OTC health products market estimates and forecasts, by form, 2018 - 2030 (USD Billion)
  • Table 21. Mexico OTC health products market estimates and forecasts, by demography, 2018 - 2030 (USD Billion)
  • Table 22. Mexico OTC health products market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Market research approaches
  • Fig. 2 Value chain-based sizing & forecasting
  • Fig. 3 Market formulation & validation
  • Fig. 4 North America OTC Health Products market segmentation
  • Fig. 5 Market driver analysis (current & future impact)
  • Fig. 6 Market restraint analysis (current & future impact)
  • Fig. 7 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 8 Porter's five forces analysis
  • Fig. 9 North America OTC health products market: Product outlook and key takeaways
  • Fig. 10 North America OTC health products market: Product movement analysis
  • Fig. 11 Cough, cold, and flu products market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 12 Liquid market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 13 Capsules/Tablets market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 14 Gummies market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 15 Others market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 16 Dietary supplements and weight loss products market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 17 Liquid market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 18 Capsules/Tablets market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 19 Gummies market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 20 Others market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 21 Sports nutrition products market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 22 Liquid market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 23 Capsules/Tablets market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 24 Gummies market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 25 Others market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 26 Probiotics market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 27 Liquid market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 28 Capsules/Tablets market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 29 Gummies market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 30 Others market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 31 CBD nutraceutical products market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 32 Liquid market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 33 Capsules/Tablets market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 34 Gummies market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 35 Others market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 36 North America OTC health products market: Application outlook and key takeaways
  • Fig. 37 North America OTC health products market: Application movement analysis
  • Fig. 38 Digestive health market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 39 Women's & men's health market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 40 Weight control market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 41 Joint health market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 42 Immune defense market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 43 Sports formulation market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 44 Others market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 45 North America OTC health products market: Form outlook and key takeaways
  • Fig. 46 North America OTC health products market: Form movement analysis
  • Fig. 47 Liquid market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 48 Capsules & tablets market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 49 Gummy market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 50 Others market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 51 North America OTC health products market: Distribution channel outlook and key takeaways
  • Fig. 52 North America OTC health products market: Distribution channel movement analysis
  • Fig. 53 Retail pharmacy market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 54 Online market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 55 Hypermarkets, supermarkets, convenience stores market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 56 Others market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 57 North America OTC health products market: Demography outlook and key takeaways
  • Fig. 58 North America OTC health products market: Demography movement analysis
  • Fig. 59 Children market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 60 Adults market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 61 North America market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 62 US market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 63 Canada market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 64 Mexico market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 65 List of key emerging company's/disruptors/innovators